476 related articles for article (PubMed ID: 16121316)
1. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid therapy for pulmonary arterial hypertension.
Strauss WL; Edelman JD
Clin Chest Med; 2007 Mar; 28(1):127-42; ix. PubMed ID: 17338932
[TBL] [Abstract][Full Text] [Related]
4. Inhaled iloprost in pulmonary arterial hypertension.
Baker SE; Hockman RH
Ann Pharmacother; 2005; 39(7-8):1265-74. PubMed ID: 15976392
[TBL] [Abstract][Full Text] [Related]
5. Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
Fink AN; Frishman WH; Azizad M; Agarwal Y
Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J; Mathen F; Herzig S; Wassermann K
Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
[No Abstract] [Full Text] [Related]
7. [Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension].
Osvaldo Cáneva J; Ossés JM
Medicina (B Aires); 2003; 63(3):233-6. PubMed ID: 12876911
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.
Dandel M; Hetzer R
Curr Vasc Pharmacol; 2003 Jun; 1(2):171-81. PubMed ID: 15320842
[TBL] [Abstract][Full Text] [Related]
9. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
11. New and future therapies in pulmonary arterial hypertension.
Bull TM
Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy.
Myers SA; Ahearn GS; Angelica Selim M; Tapson VF
J Am Acad Dermatol; 2004 Jul; 51(1):98-102. PubMed ID: 15243533
[TBL] [Abstract][Full Text] [Related]
13. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N
J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary arterial hypertension.
Murali S
Curr Opin Crit Care; 2006 Jun; 12(3):228-34. PubMed ID: 16672782
[TBL] [Abstract][Full Text] [Related]
15. Treprostinil for pulmonary hypertension.
Vachiéry JL; Naeije R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
[TBL] [Abstract][Full Text] [Related]
16. Emerging medical therapies for pulmonary arterial hypertension.
Galiè N; Manes A; Branzi A
Prog Cardiovasc Dis; 2002; 45(3):213-24. PubMed ID: 12525997
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
[TBL] [Abstract][Full Text] [Related]
18. Iloprost for idiopathic pulmonary arterial hypertension.
Leuchte HH; Behr J
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):215-23. PubMed ID: 15853595
[TBL] [Abstract][Full Text] [Related]
19. Advances in prostacyclin therapy for pulmonary arterial hypertension.
Eells PL
Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
[No Abstract] [Full Text] [Related]
20. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
Saji T; Nakayama T; Ishikita T; Matsuura H
Nihon Rinsho; 2001 Jun; 59(6):1132-8. PubMed ID: 11411125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]